NCT01122602View on ClinicalTrials.gov

Evaluate Analgesic Efficacy of Fast Release Aspirin

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

April 29, 2010

Primary Completion Date

July 29, 2010

Study Completion Date

August 6, 2010

Conditions
Drugs, Investigational
Interventions
DRUG

Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)

Single dose of fast acting aspirin 2 x 325 mg = 650 mg total

DRUG

Acetylsalicyclic acid (Aspirin, BAYE4465)

Single dose of regular aspirin 2 x 325 mg = 650 mg total

DRUG

Placebo

Two placebo tablets

Trial Locations (2)

78705

Austin

84124

Salt Lake City

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY